MON2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.349600E-01
Normal-vs-Stage2
1.383800E-01
Normal-vs-Stage3
2.295600E-01
Normal-vs-Stage4
6.436400E-01
Stage1-vs-Stage2
2.257600E-02
Stage1-vs-Stage3
2.413800E-02
Stage1-vs-Stage4
4.862000E-01
Stage2-vs-Stage3
2.435800E-04
Stage2-vs-Stage4
4.253400E-01
Stage3-vs-Stage4
8.362600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.599200E-01
Normal-vs-AfricanAmerican
5.596800E-01
Normal-vs-Asian
9.429600E-02
Caucasian-vs-AfricanAmerican
8.600400E-01
Caucasian-vs-Asian
1.052830E-01
AfricanAmerican-vs-Asian
1.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.919450E-01
Normal-vs-Female
4.640400E-01
Male-vs-Female
6.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.984600E-01
Normal-vs-Age(41-60Yrs)
5.228400E-01
Normal-vs-Age(61-80Yrs)
2.788000E-01
Normal-vs-Age(81-100Yrs)
2.671400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.840200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.104800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.794400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.290200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.193190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.513600E-02
Normal-vs-Daily Drinker
4.195800E-01
Normal-vs-Weekly Drinker
1.455180E-01
Normal-vs-Occasional Drinker
8.651600E-01
Normal-vs-Social Drinker
7.580000E-01
Non Drinker-vs-Daily Drinker
9.842600E-01
Non Drinker-vs-Weekly Drinker
8.386200E-01
Non Drinker-vs-Occasional Drinker
1.706560E-01
Non Drinker-vs-Social Drinker
1.559230E-01
Daily Drinker-vs-Weekly Drinker
8.458400E-01
Daily Drinker-vs-Occasional Drinker
1.671970E-01
Daily Drinker-vs-Social Drinker
1.528760E-01
Weekly Drinker-vs-Occasional Drinker
1.625370E-01
Weekly Drinker-vs-Social Drinker
1.570840E-01
Occasional Drinker-vs-Social Drinker
8.886000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.604810E-01
Normal-vs-Grade 2
1.551940E-02
Normal-vs-Grade 3
1.334390E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.058970E-01
Grade 1-vs-Grade 3
1.433760E-01
Grade 1-vs-Grade 4
1.604810E-01
Grade 2-vs-Grade 3
7.390800E-01
Grade 2-vs-Grade 4
1.551940E-02
Grade 3-vs-Grade 4
1.334390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.207800E-01
Normal-vs-NonDiabetic
3.345800E-01
Diabetic-vs-NonDiabetic
1.807410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.532200E-01
Normal-vs-NoPancreatitis
2.971400E-01
Pancreatitis-vs-NoPancreatitis
3.566000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.367000E-01
Normal-vs-N1
1.368020E-01
N0-vs-N1
2.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.039000E-01
Normal-vs-TP53-NonMutant
8.267400E-01
TP53-Mutant-vs-TP53-NonMutant
1.607510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
